SlideShare une entreprise Scribd logo
1  sur  18
Télécharger pour lire hors ligne
New Global Healthcare
Another Chapter In Healthcare Marketing Brand Management




www.HealthcareMedicalPharmaceuticalDirectory.com
 Healthcare
 Medical
 Pharmaceutical
 Directory

 .COM
New Global Healthcare
Another Chapter In Healthcare Marketing Brand Management
New Global Healthcare
Another Chapter In Healthcare Brand Management


  •   New Global Healthcare
  •   Brazil
  •   China
  •   India
  •   Saudi Arabia
  •   Shared Change Drivers
  •   Market Transition Indicators
  •   Ten Global Healthcare Marketing Priorities
New Global Healthcare
• Leading healthcare companies have made significant entries
into emerging markets such as Brazil, China, India and Saudi Arabia

• They have introduced new products into emerging market nations,
often establishing deeper ties including:

    o Acquisition of domestic healthcare manufacturers

    o API sourcing

    o Construction of manufacturing plants and research facilities

    o Partnerships with governments and domestic producers

    o Assertive product positioning with healthcare professionals,
      payers and patients
New Global Healthcare
•    Emerging markets are quickly maturing due to:

      o Governments and healthcare communities directly involved
        with cost/outcomes assessment and the establishment of care
        and payer structures

      o Increasing number of people with greater access to care

      o Permanence of national industrialization and modernization

      o Fortified relationships between domestic and foreign healthcare
        industry counterparts

      o Greater access to advanced bio and IT technology
New Global Healthcare
• Many emerging markets have already entered a new phase of
existence and are no longer open field running opportunities of
revenue for companies headquartered outside their borders

• More nations are closely managing outside access to their medical
communities and patient populations

• Healthcare as an industry is seen as an economic growth engine
for developing nations with domestic as well as export income benefits

• Competition is occurring among healthcare companies within the
emerging market nations and with those outside their borders
New Global Healthcare
• Along with many others, Brazil, China, India and Saudi Arabia are
are becoming “Intermediate” or “Established” markets

• The evolution of the emerging markets has created new business
environments with corresponding issues and opportunities for
healthcare companies and global brand management
Brazil
• Brazil’s Minister for Health and Aging administers national health
policy, healthcare is through private and government institutions, de-
centralization is widening, more of it is overseen by individual states

• About one-third of population has health insurance, 75% are
through commercial operators or companies with self-managed plans

• Brazil’s government strongly supports manufacture and use of
generic drugs within the nation’s healthcare system

• 15,000 pharmacies participate in “Pharmacia Popular” and “Health
Has No Price” programs which distribute products at minimal or no
cost to patients

• Attracted to disease-targeting “bull's-eye” therapies for
cholesterol, diabetes, hypertension
China
•    20% of world population, 1.5% of global pharmaceutical market

• 3,000+ drug companies, one-third owned by government, with
complete product development, manufacturing and distribution
capabilities for domestic needs as well as global export

• 3-tiered distribution system increasingly tied together via enhanced
information systems offering improved logistics and reporting

• Very large portion of market is hospitals and hospital-based
pharmacies with rapidly growing retail pharmacy segment

• High affinity for IV/injectable treatment options evolving into a new
trend demanding oral agent options not requiring close care
monitoring or hospitalizaton
India
• World’s 2nd largest population, largely rural, healthcare industry
expected to reach $280 billion dollars annually by 2020

• Upper/middle class have access to high level of care, one-third of
nation is impoverished, has access to only substandard care

• National health insurance program has 4,000+ hospitals and over
15 million families enrolled –this continues to substantially grow

• Roughly 98% of healthcare expenditures are paid in cash, about
65% of those patients are indebted for life due to medical expenses

• Government limits full access to medications but is gradually
allowing more treatment options at controlled prices

• Large number of foreign investors (mid-to-large global
pharmaceutical manufacturers) acquiring or partnering with
India-based companies
Saudi Arabia
• The Ministry of Health is primary agency overseeing healthcare
system, government group health plans include Ministry of Defense
and Aviation, Ministry of Interior, Saudi Arabian National Guard and
Ministry of Education Ministry of Labor and Social Affairs

• Employer health plans include Saudi Arabian Airlines and Royal
Commission for Jubail and Yanbu (two industrial cities)

• Government healthcare spending from 2009-2011 increases care
services by 12.4%, pharmaceuticals 8.2% and medical devices 13.3%

• Focused development of healthcare resources with growing
number of clinicians and capabilities to deliver advanced care

• Saudi Arabia is developing a domestic pharmaceutical
industry to satisfy 40% of national healthcare needs by 2022
Shared Change Drivers
• New patient populations are created by more nations providing low
income citizens access to healthcare supported by advanced clinical
and technology resources coupled with formal healthcare benefit plans

• Accelerated industrialization propels demand by increasing the flow
of funds, magnifying healthcare issues and expediting policy decisions

• Governments with ownership stakes in domestic pharmaceutical
manufacturers and/or investing in developing their own free-enterprise
healthcare industry sectors represent a challenge to outside companies

•    Medical/government leaders deciding treatment options:

      o   Cost/clinical evaluation of therapies
      o   Price controls
      o   Generic formulations strongly preferred
      o   Products produced domestically are favored
Market Transition Indicators
• Widening adoption of contemporary healthcare methods and
technology including procedures and therapies versus “traditional”
means

• Introduction/expansion of private employer-based healthcare
benefits for workers and premium-based healthcare plans issued by
governments and/or commercial insurers featuring benefit options

• Expansion of permanent healthcare provider presence (clinicians,
hospitals, clinics, pharmacies, etc.) beyond metropolitan zones into
rural areas

• Higher levels of clinician expertise with greater ability to manage
more challenging patient healthcare issues
Market Transition Indicators
• Establishment of domestic healthcare industry including product
development/manufacturing capable of satisfying national needs as
well as producing quantities to export

• Active health economic outcomes monitoring by government and
domestic healthcare community to determine optimum care/cost
combinations and ongoing evaluation of treatment options

• Growing economies enabling nations to invest more funds in the
healthcare infrastructure needed to support their population

• Changes in physician/patient access to therapies and other
products due to plan coverage rules implemented by commercial
or government payers
Ten Global Healthcare
Marketing Priorities
• During pipeline development, compounds need to be evaluated as
to what markets they may/may not have a place in and what their true
global commercial viability is

• Brand, clinical, financial and regulatory positions need to be aligned
according to global market strategy and further refined by individual
markets to maintain physician/patient access to therapies and products

• Relationships with governments and healthcare communities in
their nation must be influential and integrally involved in policy-making

• Contracting, legal and trade relation activities/processes should
blend with inherent commercial models established in each nation
Ten Global Healthcare
Marketing Priorities
• New and established brand agents need to be positioned against
brand or generic global competitors and the products of the domestic
producers in each nation

• Calibration and function of profit models require close alignment
with dynamics/market potential of each nation and global brand plan

• Contingency planning for government mandates that may enact
sweeping changes for a nation’s entire healthcare system need
ongoing maintenance

• Partnerships with domestic healthcare companies in certain
markets may be necessary business arrangements and bring
stability to the brand and corporate objectives there
Ten Global Healthcare
Marketing Priorities
• The brand’s value proposition, key messaging and clinical position
need to be fluid to remain effective in the midst of ongoing change in a
particular nation --but may remain fixed in a neighboring country

• To be competitive, healthcare companies need to quickly identify
when “Emerging Market” nations mature into “Intermediate” or
“Established” markets, adjust their business models and re-position
their brands to keep pace with evolving demands and maintain their
lead in the global marketplace
For ongoing business and clinical healthcare industry
resources, please go to:


www.HealthcareMedicalPharmaceuticalDirectory.com


  Healthcare
  Medical
  Pharmaceutical
  Directory

  .COM

Contenu connexe

Tendances

Healthcare Management PowerPoint Presentation Slides
Healthcare Management PowerPoint Presentation SlidesHealthcare Management PowerPoint Presentation Slides
Healthcare Management PowerPoint Presentation Slides
SlideTeam
 

Tendances (20)

OBM752-Hospital Management Unit:1
OBM752-Hospital Management Unit:1OBM752-Hospital Management Unit:1
OBM752-Hospital Management Unit:1
 
Recent trends in healthcare technology
Recent trends in healthcare technologyRecent trends in healthcare technology
Recent trends in healthcare technology
 
Powerpoint presentation on EHR
Powerpoint presentation on EHRPowerpoint presentation on EHR
Powerpoint presentation on EHR
 
Scope for Biomedical Engineers
Scope for Biomedical EngineersScope for Biomedical Engineers
Scope for Biomedical Engineers
 
Bio Medical Engineering
Bio Medical Engineering Bio Medical Engineering
Bio Medical Engineering
 
e-health
e-healthe-health
e-health
 
Smart hospitals
Smart hospitalsSmart hospitals
Smart hospitals
 
Hybrid assistive system
Hybrid assistive systemHybrid assistive system
Hybrid assistive system
 
Clinical decision support systems
Clinical decision support systemsClinical decision support systems
Clinical decision support systems
 
Biomedical engineering presentation
Biomedical engineering presentationBiomedical engineering presentation
Biomedical engineering presentation
 
The Future of Digital Health in 2022
The Future of Digital Health in 2022The Future of Digital Health in 2022
The Future of Digital Health in 2022
 
Job scope for biomedical engineers
Job scope for biomedical engineersJob scope for biomedical engineers
Job scope for biomedical engineers
 
introduction to biomedical engineering, Applications of biomedical engineering
introduction to biomedical engineering, Applications of biomedical engineeringintroduction to biomedical engineering, Applications of biomedical engineering
introduction to biomedical engineering, Applications of biomedical engineering
 
MEASUREMENT OF BIO POTENTIAL USING TWO ELECTRODES AND RECORDING PROBLEMS
MEASUREMENT OF BIO POTENTIAL  USING TWO ELECTRODES AND RECORDING PROBLEMSMEASUREMENT OF BIO POTENTIAL  USING TWO ELECTRODES AND RECORDING PROBLEMS
MEASUREMENT OF BIO POTENTIAL USING TWO ELECTRODES AND RECORDING PROBLEMS
 
Healthcare Management PowerPoint Presentation Slides
Healthcare Management PowerPoint Presentation SlidesHealthcare Management PowerPoint Presentation Slides
Healthcare Management PowerPoint Presentation Slides
 
Central monitoring system in healthcare
Central monitoring system in healthcareCentral monitoring system in healthcare
Central monitoring system in healthcare
 
Biomedical engineering and recent trends
Biomedical engineering and recent trendsBiomedical engineering and recent trends
Biomedical engineering and recent trends
 
Electrical safety
Electrical safetyElectrical safety
Electrical safety
 
Hospital challanges
Hospital challangesHospital challanges
Hospital challanges
 
Patient monitoring system
Patient monitoring systemPatient monitoring system
Patient monitoring system
 

En vedette

Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
PM Society
 
Classification of diseases of cns
Classification of diseases of cnsClassification of diseases of cns
Classification of diseases of cns
raj kumar
 
Central Nervous System 1
Central Nervous System 1Central Nervous System 1
Central Nervous System 1
MBBS IMS MSU
 

En vedette (12)

Achieving Managed Care Pull-Through Performance - Healthcare And Pharmaceutic...
Achieving Managed Care Pull-Through Performance - Healthcare And Pharmaceutic...Achieving Managed Care Pull-Through Performance - Healthcare And Pharmaceutic...
Achieving Managed Care Pull-Through Performance - Healthcare And Pharmaceutic...
 
Key Concepts, Challenges and Opportunities For Health Insurance Exchanges - ...
Key Concepts, Challenges and Opportunities For Health Insurance Exchanges  - ...Key Concepts, Challenges and Opportunities For Health Insurance Exchanges  - ...
Key Concepts, Challenges and Opportunities For Health Insurance Exchanges - ...
 
CNS_Fact_Sheet
CNS_Fact_SheetCNS_Fact_Sheet
CNS_Fact_Sheet
 
Drug prices and_market_access_across_europe_webcast_european_turmoil_2012
Drug prices and_market_access_across_europe_webcast_european_turmoil_2012Drug prices and_market_access_across_europe_webcast_european_turmoil_2012
Drug prices and_market_access_across_europe_webcast_european_turmoil_2012
 
Pharma Maket Access - Southeast Europe & Turkey
Pharma Maket Access - Southeast Europe  & TurkeyPharma Maket Access - Southeast Europe  & Turkey
Pharma Maket Access - Southeast Europe & Turkey
 
Future of Market Access – a Pharma Perspective
Future of Market Access – a Pharma PerspectiveFuture of Market Access – a Pharma Perspective
Future of Market Access – a Pharma Perspective
 
McKinsey case study - innovation in pharma
McKinsey case study - innovation in pharma McKinsey case study - innovation in pharma
McKinsey case study - innovation in pharma
 
Ati flash cards 05, medications affecting the nervous system
Ati flash cards 05, medications affecting the nervous systemAti flash cards 05, medications affecting the nervous system
Ati flash cards 05, medications affecting the nervous system
 
Classification of diseases of cns
Classification of diseases of cnsClassification of diseases of cns
Classification of diseases of cns
 
Drugs that act on CNS
Drugs that act on CNSDrugs that act on CNS
Drugs that act on CNS
 
Central Nervous System 1
Central Nervous System 1Central Nervous System 1
Central Nervous System 1
 
LinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-PresentedLinkedIn SlideShare: Knowledge, Well-Presented
LinkedIn SlideShare: Knowledge, Well-Presented
 

Similaire à Global Healthcare Marketing And Market Access Concepts - Managed Care Applications - John Baresky, #baresky

Ppt_Ankit_Medicaid
Ppt_Ankit_MedicaidPpt_Ankit_Medicaid
Ppt_Ankit_Medicaid
Ankit Raheja
 
HIMSS15_TeleHealth Strategy_118Final
HIMSS15_TeleHealth Strategy_118FinalHIMSS15_TeleHealth Strategy_118Final
HIMSS15_TeleHealth Strategy_118Final
Jeff Jones
 
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply Chain
The New Pharma Ecosystem:  2014 Trends Reshaping the Pharmaceutical Supply ChainThe New Pharma Ecosystem:  2014 Trends Reshaping the Pharmaceutical Supply Chain
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply Chain
Laura Olson
 

Similaire à Global Healthcare Marketing And Market Access Concepts - Managed Care Applications - John Baresky, #baresky (20)

New Global Healthcare Another Chapter In Healthcare Marketing Brand Management
New Global Healthcare Another Chapter In Healthcare Marketing Brand ManagementNew Global Healthcare Another Chapter In Healthcare Marketing Brand Management
New Global Healthcare Another Chapter In Healthcare Marketing Brand Management
 
New Global Healthcare - Another Chapter In Healthcare Marketing Brand Management
New Global Healthcare - Another Chapter In Healthcare Marketing Brand ManagementNew Global Healthcare - Another Chapter In Healthcare Marketing Brand Management
New Global Healthcare - Another Chapter In Healthcare Marketing Brand Management
 
National Health policy
National Health policyNational Health policy
National Health policy
 
Marketing Plan (Tractor Drug Company)
Marketing Plan (Tractor Drug Company) Marketing Plan (Tractor Drug Company)
Marketing Plan (Tractor Drug Company)
 
Market Analysis for Medicines Segment of Healthcare Sector
Market Analysis for Medicines Segment of Healthcare SectorMarket Analysis for Medicines Segment of Healthcare Sector
Market Analysis for Medicines Segment of Healthcare Sector
 
Pharma trends in bric economies
Pharma trends in bric economiesPharma trends in bric economies
Pharma trends in bric economies
 
mHealth Israel_US Health Insurance Overview- An Insider's Perspective
mHealth Israel_US Health Insurance Overview- An Insider's PerspectivemHealth Israel_US Health Insurance Overview- An Insider's Perspective
mHealth Israel_US Health Insurance Overview- An Insider's Perspective
 
Pharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and IntelligencePharmaceutical Supply Chain Dynamics and Intelligence
Pharmaceutical Supply Chain Dynamics and Intelligence
 
Responsible Business Practices in the Health Sector
Responsible Business Practices in the Health SectorResponsible Business Practices in the Health Sector
Responsible Business Practices in the Health Sector
 
Ppt_Ankit_Medicaid
Ppt_Ankit_MedicaidPpt_Ankit_Medicaid
Ppt_Ankit_Medicaid
 
eHealth business opportunities and things to consider when entering the USA m...
eHealth business opportunities and things to consider when entering the USA m...eHealth business opportunities and things to consider when entering the USA m...
eHealth business opportunities and things to consider when entering the USA m...
 
Dynamics Impacting the Future of Healthcare
Dynamics Impacting the Future of HealthcareDynamics Impacting the Future of Healthcare
Dynamics Impacting the Future of Healthcare
 
India’s Pharma Export Boosting Sales and the Added Value.pptx
India’s Pharma Export Boosting Sales and the Added Value.pptxIndia’s Pharma Export Boosting Sales and the Added Value.pptx
India’s Pharma Export Boosting Sales and the Added Value.pptx
 
Intro to Healthcare for Interns
Intro to Healthcare for InternsIntro to Healthcare for Interns
Intro to Healthcare for Interns
 
GetPersonalized! Pharma's perspective on the future, Claudia Karnbach
GetPersonalized! Pharma's perspective on the future, Claudia KarnbachGetPersonalized! Pharma's perspective on the future, Claudia Karnbach
GetPersonalized! Pharma's perspective on the future, Claudia Karnbach
 
Global new entrants are resetting the axes of the global healthcare and welln...
Global new entrants are resetting the axes of the global healthcare and welln...Global new entrants are resetting the axes of the global healthcare and welln...
Global new entrants are resetting the axes of the global healthcare and welln...
 
Etude PwC "Global health’s new entrants: Meeting the world’s consumer" (mars ...
Etude PwC "Global health’s new entrants: Meeting the world’s consumer" (mars ...Etude PwC "Global health’s new entrants: Meeting the world’s consumer" (mars ...
Etude PwC "Global health’s new entrants: Meeting the world’s consumer" (mars ...
 
HIMSS15_TeleHealth Strategy_118Final
HIMSS15_TeleHealth Strategy_118FinalHIMSS15_TeleHealth Strategy_118Final
HIMSS15_TeleHealth Strategy_118Final
 
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply Chain
The New Pharma Ecosystem:  2014 Trends Reshaping the Pharmaceutical Supply ChainThe New Pharma Ecosystem:  2014 Trends Reshaping the Pharmaceutical Supply Chain
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply Chain
 
Evolution of the healthcare industry in India and the potential impact of the...
Evolution of the healthcare industry in India and the potential impact of the...Evolution of the healthcare industry in India and the potential impact of the...
Evolution of the healthcare industry in India and the potential impact of the...
 

Plus de Bare Sky Marketing Healthcare Content Writing Services

Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...
Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...
Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...
Bare Sky Marketing Healthcare Content Writing Services
 
Is Walgreens Going Private or In The Process Of Being Acquired? John G. Baresky
Is Walgreens Going Private or In The Process Of Being Acquired? John G. BareskyIs Walgreens Going Private or In The Process Of Being Acquired? John G. Baresky
Is Walgreens Going Private or In The Process Of Being Acquired? John G. Baresky
Bare Sky Marketing Healthcare Content Writing Services
 
Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator - ...
Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator  - ...Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator  - ...
Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator - ...
Bare Sky Marketing Healthcare Content Writing Services
 
Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...
Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...
Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...
Bare Sky Marketing Healthcare Content Writing Services
 
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
Bare Sky Marketing Healthcare Content Writing Services
 
Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...
Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...
Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...
Bare Sky Marketing Healthcare Content Writing Services
 
Healthcare Digital Marketing ROI: Boost It With Infographs - John G. Baresk...
Healthcare Digital Marketing ROI:  Boost It With Infographs -  John G. Baresk...Healthcare Digital Marketing ROI:  Boost It With Infographs -  John G. Baresk...
Healthcare Digital Marketing ROI: Boost It With Infographs - John G. Baresk...
Bare Sky Marketing Healthcare Content Writing Services
 

Plus de Bare Sky Marketing Healthcare Content Writing Services (20)

Washington Takes Action To Help Rural Healthcare - John G. Baresky
Washington Takes Action To Help Rural Healthcare -  John G. BareskyWashington Takes Action To Help Rural Healthcare -  John G. Baresky
Washington Takes Action To Help Rural Healthcare - John G. Baresky
 
WALGREENS AND DOORDASH SIGN DELIVERY PARTNERSHIP - John G. Baresky
WALGREENS AND DOORDASH SIGN DELIVERY PARTNERSHIP - John G. BareskyWALGREENS AND DOORDASH SIGN DELIVERY PARTNERSHIP - John G. Baresky
WALGREENS AND DOORDASH SIGN DELIVERY PARTNERSHIP - John G. Baresky
 
Bare Sky Marketing Healthcare Content Writing Services - John G. Baresky
Bare Sky Marketing Healthcare Content Writing Services - John G. BareskyBare Sky Marketing Healthcare Content Writing Services - John G. Baresky
Bare Sky Marketing Healthcare Content Writing Services - John G. Baresky
 
Lynparza (olaparib) Gains New Oncology Indication for Prostate Cancer - John...
Lynparza (olaparib) Gains New Oncology Indication for Prostate Cancer -  John...Lynparza (olaparib) Gains New Oncology Indication for Prostate Cancer -  John...
Lynparza (olaparib) Gains New Oncology Indication for Prostate Cancer - John...
 
ALEXION PHARMACEUTICALS ACQUIRES PORTOLA PHARMACEUTICALS: $1.41 BILLION - Joh...
ALEXION PHARMACEUTICALS ACQUIRES PORTOLA PHARMACEUTICALS: $1.41 BILLION - Joh...ALEXION PHARMACEUTICALS ACQUIRES PORTOLA PHARMACEUTICALS: $1.41 BILLION - Joh...
ALEXION PHARMACEUTICALS ACQUIRES PORTOLA PHARMACEUTICALS: $1.41 BILLION - Joh...
 
RURAL HOSPITALS NEED A CURE FAST - John G. Baresky
RURAL HOSPITALS NEED A CURE FAST - John G. BareskyRURAL HOSPITALS NEED A CURE FAST - John G. Baresky
RURAL HOSPITALS NEED A CURE FAST - John G. Baresky
 
7 Drivers: Pharmaceutical Television Advertising - John G. Baresky
7 Drivers: Pharmaceutical Television Advertising - John G. Baresky7 Drivers: Pharmaceutical Television Advertising - John G. Baresky
7 Drivers: Pharmaceutical Television Advertising - John G. Baresky
 
Coronavirus 2019-nCoV: A Public Health Emergency of International Concern (PH...
Coronavirus 2019-nCoV: A Public Health Emergency of International Concern (PH...Coronavirus 2019-nCoV: A Public Health Emergency of International Concern (PH...
Coronavirus 2019-nCoV: A Public Health Emergency of International Concern (PH...
 
Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...
Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...
Alphabet ( Parent Company of Google and Verily ) Hires Dr. Karen B. DeSalvo a...
 
Is Walgreens Going Private or In The Process Of Being Acquired? John G. Baresky
Is Walgreens Going Private or In The Process Of Being Acquired? John G. BareskyIs Walgreens Going Private or In The Process Of Being Acquired? John G. Baresky
Is Walgreens Going Private or In The Process Of Being Acquired? John G. Baresky
 
Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator - ...
Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator  - ...Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator  - ...
Amazon Expands Healthcare Enterprise With Acquisition of Health Navigator - ...
 
Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...
Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...
Merck Keytruda and Eisai Lenvima Achieve Triple Approval In Oncology And Wome...
 
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeu...
 
Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...
Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...
Amazon And Pill Pack Have Options: How May A Federal Trade Commission Antitru...
 
State Of Digital Healthcare In 2017 - HIMSS - John G. Baresky
State Of Digital Healthcare In 2017 - HIMSS - John G. Baresky State Of Digital Healthcare In 2017 - HIMSS - John G. Baresky
State Of Digital Healthcare In 2017 - HIMSS - John G. Baresky
 
DELOITTE: 2017 Global Health Sciences Outlook Report - - John G. Baresky
DELOITTE: 2017 Global Health Sciences Outlook Report - - John G. Baresky DELOITTE: 2017 Global Health Sciences Outlook Report - - John G. Baresky
DELOITTE: 2017 Global Health Sciences Outlook Report - - John G. Baresky
 
Healthcare Digital Marketing ROI: Boost It With Infographs - John G. Baresky...
Healthcare Digital Marketing ROI:  Boost It With Infographs - John G. Baresky...Healthcare Digital Marketing ROI:  Boost It With Infographs - John G. Baresky...
Healthcare Digital Marketing ROI: Boost It With Infographs - John G. Baresky...
 
Healthcare Digital Marketing ROI: Boost It With Infograph Sharing - John G. ...
Healthcare Digital Marketing ROI:  Boost It With Infograph Sharing - John G. ...Healthcare Digital Marketing ROI:  Boost It With Infograph Sharing - John G. ...
Healthcare Digital Marketing ROI: Boost It With Infograph Sharing - John G. ...
 
Healthcare Digital Marketing ROI: Boost It With Infographs - John G. Baresk...
Healthcare Digital Marketing ROI:  Boost It With Infographs -  John G. Baresk...Healthcare Digital Marketing ROI:  Boost It With Infographs -  John G. Baresk...
Healthcare Digital Marketing ROI: Boost It With Infographs - John G. Baresk...
 
The Mechanics Of Deductibles, Big Data And Healthcare Marketing - John G. Bar...
The Mechanics Of Deductibles, Big Data And Healthcare Marketing - John G. Bar...The Mechanics Of Deductibles, Big Data And Healthcare Marketing - John G. Bar...
The Mechanics Of Deductibles, Big Data And Healthcare Marketing - John G. Bar...
 

Dernier

Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
daisycvs
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
Nauman Safdar
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
instagramfab782445
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
allensay1
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
ZurliaSoop
 

Dernier (20)

Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
Pre Engineered Building Manufacturers Hyderabad.pptx
Pre Engineered  Building Manufacturers Hyderabad.pptxPre Engineered  Building Manufacturers Hyderabad.pptx
Pre Engineered Building Manufacturers Hyderabad.pptx
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
How to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League CityHow to Get Started in Social Media for Art League City
How to Get Started in Social Media for Art League City
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' Slideshare
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
 
Rice Manufacturers in India | Shree Krishna Exports
Rice Manufacturers in India | Shree Krishna ExportsRice Manufacturers in India | Shree Krishna Exports
Rice Manufacturers in India | Shree Krishna Exports
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
Buy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From SeosmmearthBuy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From Seosmmearth
 
Falcon Invoice Discounting: Tailored Financial Wings
Falcon Invoice Discounting: Tailored Financial WingsFalcon Invoice Discounting: Tailored Financial Wings
Falcon Invoice Discounting: Tailored Financial Wings
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdf
 
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow ChallengesFalcon Invoice Discounting: Aviate Your Cash Flow Challenges
Falcon Invoice Discounting: Aviate Your Cash Flow Challenges
 
Organizational Transformation Lead with Culture
Organizational Transformation Lead with CultureOrganizational Transformation Lead with Culture
Organizational Transformation Lead with Culture
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All TimeCall 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 

Global Healthcare Marketing And Market Access Concepts - Managed Care Applications - John Baresky, #baresky

  • 1. New Global Healthcare Another Chapter In Healthcare Marketing Brand Management www.HealthcareMedicalPharmaceuticalDirectory.com Healthcare Medical Pharmaceutical Directory .COM
  • 2. New Global Healthcare Another Chapter In Healthcare Marketing Brand Management
  • 3. New Global Healthcare Another Chapter In Healthcare Brand Management • New Global Healthcare • Brazil • China • India • Saudi Arabia • Shared Change Drivers • Market Transition Indicators • Ten Global Healthcare Marketing Priorities
  • 4. New Global Healthcare • Leading healthcare companies have made significant entries into emerging markets such as Brazil, China, India and Saudi Arabia • They have introduced new products into emerging market nations, often establishing deeper ties including: o Acquisition of domestic healthcare manufacturers o API sourcing o Construction of manufacturing plants and research facilities o Partnerships with governments and domestic producers o Assertive product positioning with healthcare professionals, payers and patients
  • 5. New Global Healthcare • Emerging markets are quickly maturing due to: o Governments and healthcare communities directly involved with cost/outcomes assessment and the establishment of care and payer structures o Increasing number of people with greater access to care o Permanence of national industrialization and modernization o Fortified relationships between domestic and foreign healthcare industry counterparts o Greater access to advanced bio and IT technology
  • 6. New Global Healthcare • Many emerging markets have already entered a new phase of existence and are no longer open field running opportunities of revenue for companies headquartered outside their borders • More nations are closely managing outside access to their medical communities and patient populations • Healthcare as an industry is seen as an economic growth engine for developing nations with domestic as well as export income benefits • Competition is occurring among healthcare companies within the emerging market nations and with those outside their borders
  • 7. New Global Healthcare • Along with many others, Brazil, China, India and Saudi Arabia are are becoming “Intermediate” or “Established” markets • The evolution of the emerging markets has created new business environments with corresponding issues and opportunities for healthcare companies and global brand management
  • 8. Brazil • Brazil’s Minister for Health and Aging administers national health policy, healthcare is through private and government institutions, de- centralization is widening, more of it is overseen by individual states • About one-third of population has health insurance, 75% are through commercial operators or companies with self-managed plans • Brazil’s government strongly supports manufacture and use of generic drugs within the nation’s healthcare system • 15,000 pharmacies participate in “Pharmacia Popular” and “Health Has No Price” programs which distribute products at minimal or no cost to patients • Attracted to disease-targeting “bull's-eye” therapies for cholesterol, diabetes, hypertension
  • 9. China • 20% of world population, 1.5% of global pharmaceutical market • 3,000+ drug companies, one-third owned by government, with complete product development, manufacturing and distribution capabilities for domestic needs as well as global export • 3-tiered distribution system increasingly tied together via enhanced information systems offering improved logistics and reporting • Very large portion of market is hospitals and hospital-based pharmacies with rapidly growing retail pharmacy segment • High affinity for IV/injectable treatment options evolving into a new trend demanding oral agent options not requiring close care monitoring or hospitalizaton
  • 10. India • World’s 2nd largest population, largely rural, healthcare industry expected to reach $280 billion dollars annually by 2020 • Upper/middle class have access to high level of care, one-third of nation is impoverished, has access to only substandard care • National health insurance program has 4,000+ hospitals and over 15 million families enrolled –this continues to substantially grow • Roughly 98% of healthcare expenditures are paid in cash, about 65% of those patients are indebted for life due to medical expenses • Government limits full access to medications but is gradually allowing more treatment options at controlled prices • Large number of foreign investors (mid-to-large global pharmaceutical manufacturers) acquiring or partnering with India-based companies
  • 11. Saudi Arabia • The Ministry of Health is primary agency overseeing healthcare system, government group health plans include Ministry of Defense and Aviation, Ministry of Interior, Saudi Arabian National Guard and Ministry of Education Ministry of Labor and Social Affairs • Employer health plans include Saudi Arabian Airlines and Royal Commission for Jubail and Yanbu (two industrial cities) • Government healthcare spending from 2009-2011 increases care services by 12.4%, pharmaceuticals 8.2% and medical devices 13.3% • Focused development of healthcare resources with growing number of clinicians and capabilities to deliver advanced care • Saudi Arabia is developing a domestic pharmaceutical industry to satisfy 40% of national healthcare needs by 2022
  • 12. Shared Change Drivers • New patient populations are created by more nations providing low income citizens access to healthcare supported by advanced clinical and technology resources coupled with formal healthcare benefit plans • Accelerated industrialization propels demand by increasing the flow of funds, magnifying healthcare issues and expediting policy decisions • Governments with ownership stakes in domestic pharmaceutical manufacturers and/or investing in developing their own free-enterprise healthcare industry sectors represent a challenge to outside companies • Medical/government leaders deciding treatment options: o Cost/clinical evaluation of therapies o Price controls o Generic formulations strongly preferred o Products produced domestically are favored
  • 13. Market Transition Indicators • Widening adoption of contemporary healthcare methods and technology including procedures and therapies versus “traditional” means • Introduction/expansion of private employer-based healthcare benefits for workers and premium-based healthcare plans issued by governments and/or commercial insurers featuring benefit options • Expansion of permanent healthcare provider presence (clinicians, hospitals, clinics, pharmacies, etc.) beyond metropolitan zones into rural areas • Higher levels of clinician expertise with greater ability to manage more challenging patient healthcare issues
  • 14. Market Transition Indicators • Establishment of domestic healthcare industry including product development/manufacturing capable of satisfying national needs as well as producing quantities to export • Active health economic outcomes monitoring by government and domestic healthcare community to determine optimum care/cost combinations and ongoing evaluation of treatment options • Growing economies enabling nations to invest more funds in the healthcare infrastructure needed to support their population • Changes in physician/patient access to therapies and other products due to plan coverage rules implemented by commercial or government payers
  • 15. Ten Global Healthcare Marketing Priorities • During pipeline development, compounds need to be evaluated as to what markets they may/may not have a place in and what their true global commercial viability is • Brand, clinical, financial and regulatory positions need to be aligned according to global market strategy and further refined by individual markets to maintain physician/patient access to therapies and products • Relationships with governments and healthcare communities in their nation must be influential and integrally involved in policy-making • Contracting, legal and trade relation activities/processes should blend with inherent commercial models established in each nation
  • 16. Ten Global Healthcare Marketing Priorities • New and established brand agents need to be positioned against brand or generic global competitors and the products of the domestic producers in each nation • Calibration and function of profit models require close alignment with dynamics/market potential of each nation and global brand plan • Contingency planning for government mandates that may enact sweeping changes for a nation’s entire healthcare system need ongoing maintenance • Partnerships with domestic healthcare companies in certain markets may be necessary business arrangements and bring stability to the brand and corporate objectives there
  • 17. Ten Global Healthcare Marketing Priorities • The brand’s value proposition, key messaging and clinical position need to be fluid to remain effective in the midst of ongoing change in a particular nation --but may remain fixed in a neighboring country • To be competitive, healthcare companies need to quickly identify when “Emerging Market” nations mature into “Intermediate” or “Established” markets, adjust their business models and re-position their brands to keep pace with evolving demands and maintain their lead in the global marketplace
  • 18. For ongoing business and clinical healthcare industry resources, please go to: www.HealthcareMedicalPharmaceuticalDirectory.com Healthcare Medical Pharmaceutical Directory .COM